GRETAP
Research Group in Therapies in Primary Care
It is a multidisciplinary group with the participation of professional members of primary care, pharmacy, statistics, with a common trajectory, initiated in 2007, in the study of pharmacological and non-pharmacological therapies prescribed to the general population. In addition, the group has collaborated and collaborated with other organizations such as the University of Lleida and INEFC with research groups of the Institute of Biomedical Research of Lleida (IRBLL) and with the Unity of Epidemiology of the Department of Health. The main objectives of the group within the area of study of pharmacological and non-pharmacological therapies are: the prevalence, efficiency, cost, adherence and reliability studies.
Group projects
|
PI: Ribes Murillo, Esther Noemi. Programa de la mejora del diagnóstico y la terapia inhalada en el paciente EPOC (INHAPOC). Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020 |
|
PI: Serna Arnaiz, Maria Catalina. Estudio de prevalencia, comorbilidad y cumplimiento terapéutico en pacientes con trastorno por déficit de atención con hiperactividad en tratamiento farmacológico.. Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020 |
|
PI: Ribes Murillo, Esther Noemi. Diagnòstic i tractament de les infeccions del tracte urinari en l'adult a l'atenció primària. Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020 |
|
PI: Solanes, Mònica. Concordance of ultrasound diagnosis between general practitioners and radiologists and patients' satisfaction with the ultrasound examination in primary care. Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020 |
|
PI: Montserrat Capdevila, Josep. Incidencia y factores de riesgo asociados a la hospitalización por exacerbación de la enfermedad pulmonar obstructiva crónica y determinación de las efectividades de las vacunaciones antigripal y antineumocócica 23-V. Funding: IDIAP Jordi Gol. Duration: 2017 - 2019 |
|
PI: Cruz Cubell, Jose Lluís. Validació científica d'una eina de detecció de dislèxia en català, determinació de la prevalença de dislèxia a Catalunya i estudi cost-efectivitat en Atenció Primària. Funding: Diputacio de Lleida. Duration: 2017 - 2019 |
|
PI: Montserrat Capdevila, Josep. Diseño y validación de modelos score predictores de riesgo de exacerbación de la Enfermedad Pulmonar Obstructiva Crónica. Funding: Laboratorios Dr. Esteve, S.A.. Duration: 2017 - 2019 |
|
PI: Pollina Pocallet, Mercè. Percepció de la imatge corporal en l'adolescència: SÓC JO? Funding: Diputacio de Lleida. Duration: 2017 - 2019 |
The group participates in the following projects
Rodrigo Claverol, MDolores. Estudi d'efectivititat de la teràpia assistida amb animals (gossos) en població infantil amb transtorn per deficit atenció i hiperactivitat (TDAH). Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020
Group Publications
|
Bañeras J, Ferreira-González I, Marsal JR, Barrabés JA, Ribera A, Lidón RM, Domingo E, Martí G, García-Dorado D; Codi IAM Registry investigators. Short-term exposure to air pollutants increases the risk of ST elevation myocardial infarction and of infarct-related ventricular arrhythmias and mortality. Int J Cardiol. 2018 Jan 1;250:35-42. doi: 10.1016/j.ijcard.2017.10.004. Epub 2017 Oct 5. PubMed PMID: 29056239. IF: 6,189. |
|
Chamandi C, Barbanti M, Munoz-Garcia A, Latib A, Nombela-Franco L, Gutiérrez-Ibanez E, Veiga-Fernandez G, Cheema AN, Cruz-Gonzalez I, Serra V, Tamburino C, Mangieri A, Colombo A, Jiménez-Quevedo P, Elizaga J, Laughlin G, Lee DH, Garcia Del Blanco B, Rodriguez-Gabella T, Marsal JR, Côté M, Philippon F, Rodés-Cabau J. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement. JACC Cardiovasc Imaging. 2018;11:301-310. PMID:29413244. IF: 10,189. |
|
Fernández-Armenteros JM, Gómez-Arbonés X, Buti-Solé M, Betriu-Bars A, Sanmartin-Novell V, Ortega-Bravo M, Martínez-Alonso M, Casanova-Seuma JM. Epidemiology of Psoriasis. A Population-Based Study. Actas dermo-sifiliograficas. 2018 Dec; doi:10.1016/j.ad.2018.10.015. Epub 2018 Dec 23. PMID:30587329. |
|
Fernández-Armenteros JM, Gómez-Arbonés X, Buti-Soler M, Betriu-Bars A, Sanmartin-Novell V, Ortega-Bravo M, Martínez-Alonso M, Garí E, Portero-Otín M, Santamaria-Babi L, Casanova-Seuma JM. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study. Journal of the European Academy of Dermatology and Venereology: JEADV. 2019 Jan; 33(1):128-135. doi:10.1111/jdv.15159. Epub 2018 Jul 17. PMID:29953676. IF: 3,528. |
|
Fernández-Hidalgo N, Ferreria-González I, Marsal JR, Ribera A, Aznar ML, de Alarcón A, García-Cabrera E, Gálvez-Acebal J, Sánchez-Espín G, Reguera-Iglesias JM, De La Torre-Lima J, Lomas JM, Hidalgo-Tenorio C, Vallejo N, Miranda B, Santos-Ortega A, Castro MA, Tornos P, García-Dorado D, Almirante B. A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE. Clin Microbiol Infect. 2018 Feb 2. pii:S1198-743X(18)30090-9. doi: 10.1016/j.cmi.2018.01.019. [Epub ahead of print] PubMed PMID: 29408350. IF: 5,292. |
|
Marsal JR, Ferreira-González I, Ribera A, Oristrell G, Pijoan JI, García-Dorado D. Bin-CE: A comprehensive web application to decide upon the best set of outcomes to be combined in a binary composite endpoint. PloS one. 2018; 13(12):e0209000. doi:10.1371/journal.pone.0209000. Epub 2018 Dec 13. pmc:PMC6292611. PMID:30543676. IF: 2,806. |
|
Montserrat-Capdevila J, Godoy P, Marsal JR, Ortega M, Barbé F, Castañ MT, Seminario MA, Pujol J, Alsedà M. Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers. Atencion primaria. 2018 Nov; doi:10.1016/j.aprim.2017.10.012. Epub 2018 Nov 16. Spanish. PMID:30454958. IF: 1,042. |
|
Montserrat-Capdevila J, Godoy P, Marsal JR, Ortega M, Pifarré J, Alsedà M, Castañ MT, Barbé F. Mental disorders in chronic obstructive pulmonary diseases. Perspectives in psychiatric care. 2018 Jul; 54(3):398-404. doi:10.1111/ppc.12274. Epub 2018 Mar 25. PMID:29577318. IF: 1,130. |
|
Montserrat-Capdevila J, Seminario MA, Godoy P, Marsal JR, Ortega M, Pujol J, Castañ MT, Alsedà M, Betriu À, Lecube A, Portero M, Purroy F, Valdivielso JM, Barbé F. Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors. Medicina clinica. 2018 Nov; 151(10):383-389. doi:10.1016/j.medcli.2017.12.018. Epub 2018 Mar 07. PMID:29525115. IF: 1,125. |
|
Nadal N, de Batlle J, Barbé F, Marsal JR, Sánchez-de-la-Torre A, Tarraubella N, Lavega M, Sánchez-de-la-Torre M. Predictors of CPAP compliance in different clinical settings: primary care versus sleep unit. Sleep & breathing = Schlaf & Atmung. 2018 03; 22(1):157-163. doi:10.1007/s11325-017-1549-7. Epub 2017 Sep 01. PMID:28865067. IF: 2,288. |
|
Pérez-Rodon J, Galve E, Pérez-Bocanegra C, Soriano-Sánchez T, Recio-Iglesias J, Domingo-Baldrich E, Alzola-Guevara M, Ferreira-González I, Marsal JR, Ribera-Solé A, Gutierrez García-Moreno L, Cruz-Carlos LM, Rivas-Gandara N, Roca-Luque I, Francisco-Pascual J, Evangelista-Masip A, Moya-Mitjans À, García-Dorado D. A risk score to predict the absence of left ventricular reverse remodeling: Implications for the timing of ICD implantation in primary prevention. J Cardiol. 2018 May;71(5):505-512. doi: 10.1016/j.jjcc.2017.10.019. Epub 2017 Nov 26. PubMed PMID: 29183646. IF: 2,732. |
|
Pontes C, Marsal JR, Elorza JM, Aragón M, Prieto-Alhambra D, Morros R. Analgesic Use and Risk for Acute Coronary Events in Patients With Osteoarthritis: A Population-based, Nested Case-control Study. Clin Ther. 2018 Feb;40(2):270-283. doi: 10.1016/j.clinthera.2017.12.011. Epub 2018 Feb 3. PubMed PMID: 29398161. IF: 2,947. |
|
Real J, Serna MC, Giner-Soriano M, Forés R, Pera G, Ribes E, Alzamora M, Marsal JR, Heras A, Morros R. Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database. BMC cardiovascular disorders. 2018 May; 18(1):85. doi:10.1186/s12872-018-0822-4. Epub 2018 May 08. PMID:29739318. IF: 1,832. |
|
Sánchez E, Lecube A, Betriu À, Hernández C, López-Cano C, Gutiérrez-Carrasquilla L, Kerkeni M, Yeramian A, Purroy F, Pamplona R, Farràs C, Fernández E, Barbé F, Simó R, Hernández M, Rius F, Polanco D, de la Torre MS, Torres G, Godoy P, Portero-Otin M, Jové M, Colàs-Compàs L, Benabdelhak I, Miquel E, Ortega M, Valdivielso JM, Bermúdez M, Martínez-Alonso M; ILERVAS project. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project. Diabetes & metabolism. 2018 Apr; doi:10.1016/j.diabet.2018.04.002. Epub 2018 Apr 13. PMID:29706471. IF: 4,101. |
|
Teixidó C, Díez O, Marsal JR, Giner-Soriano M, Pera H, Martinez M, Galindo-Ortego G, Schoenenberger JA, Real J, Cruz I, Morros R. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum. Pediatr Dermatol. 2018 May;35(3):336-342. doi: 10.1111/pde.13438. Epub 2018 Feb 26. PubMed PMID: 29479727. IF: 0,990. |
|
Yuguero O, Guzman M, Castañ T, Forné C, Galindo G, Pujol J. Characteristics and prognosis of patients admitted to a hospital emergency department for traumatic brain injury and with anticoagulant or antiplatelet treatment. Neurocirugia (Asturias, Spain). 2018 Sep; 29(5):233-239. doi:10.1016/j.neucir.2018.05.001. Epub 2018 Jun 10. PMID:29898869. IF: 0,548. |
Indicators
|
Indicator |
2018 |
|---|---|
|
Researchers with PhD |
5 |
|
Total number of projects in which group members have participated |
9 |
|
Total number of projects in which the PI of the project has belonged to the group |
3 |
|
Total Funding |
37.750,00€ |
|
Scientific publications in indexed journals |
15 |
|
Total Impact factor |
46,74 |
|
Nº of articles in Q1 journals |
6 |
|
Q1 IF |
32,105 |
|
Nº of articles in Q2 journals |
2 |
|
Q2 IF |
5,679 |
